OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-03-31-accounts

Paul Garvin Chairman
to 31stJanuary 2021
Neil Mundy Interim Joint Chairman
from 1stFebruary 2021 tc31stJuly 2021
Derek Bell Joint Chairman
from 1st September 2021
Julia Ann Gillon Chief Executive
Anandapuram Deepak Dwarakanath Medical Director /Deputy
Chief Executive
Alan Sheppard Chief People Officer
Neil Atkinson Director ofFinance
Julie Lane Director ofNursing,
Patient Safety
and Quality to30th November 2020
Graham
Evens
Lynne Taylor
Chief Information
Technology
Offfcer
Director of Planning 6 Performance
Barbara Bright Director ofCorporate Affairs and Chief ofStaff
Levi Buckley Chief Operating
Officer
Stephen
Hall
Vice Chairman
and Non-executive
Director
Rita Taylor Non-executive
Director
Jonathan
Erskine
Non-executive
Director
Kevin Robinson Non-executive
Director
Philip Craig Nonwxecutive
Director
Ann Baxter Associate Non-executive
Director
Neil Schneider Associate Non-executive
Director
Undsey Robertson Director of Nursing,
Paffent Safety
and Quality from 1st September 2020
The Executive Directors and Non-executive
Directors ofthe Foundation
Trust Board are
the Trustee ofthe Charity.
The Executive Directors are appointed by the
Non-executive
Directors
and the Governors appoint the Non-
executive Directors.

~E* cht coo
Lucera Bronchoscope 27
Mini Probe 5
Oefibriltator 6
Motomed
Muvi active Exercise plus
7
Innaspire
deluxe reusable sidestream
& kit 5
MSK Ultrasound system 17
Accuvein 5
Fluent System 27
Hysterscope 25
Other medical equipment
143

ajor refurbishments and IT equipm ent
purchases
during the year ar
e shown
below:
~EDD EDDD
Vocera volunteers communication badges and chargers 9
48x Dementia
Touch screen tablets
12
LED Ceiling Mural 8
Other refurbishment costs
38

erate d
char
itable fun ds in come will support
patient car
e and benefits, staff health and wellbeing.
~EditlEOOD
Staff loNeiy winnings paid
Staff loNery administration costs
12

Statement of Financia l Ac tivities for the y ear ended 31 March 2021
Total Total
Note Unrestricted Reslrlrsed Funds Funds
Funds Funds 2020/21 2019/2D
f000 f000 f000 fOOD
Income and endowments from:
Donations 3 440 107 547 341
Legacies 3 16 16 118
Charitable
activities
4 20 20 15
Other trading activities-staff lottery 5 17 17
Other incoming
resources
6 61 5 66 100
Investment
Income
13.3 14 26 40 39
Total incoming resources 515 191 706 6'I3
Expenditure
on:
Raising Funds 12 12
Charitable
activities:
Research Posts and Clinical Care 29 29 72
Purchase ofEquipment 69 74 143 60
Refurbishment
costs
9 29 38 80
Stafl Education
and Welfare
160 18 178 62
Patient Welfare 1 9 10 37
Governance
Costs
10 13 24 37 35
Total expenditure
Net gain/(losses)
on investments
13.1 252
84
195
149
233 ~3
Net income/(expenditure) before transfers 347 145 492 230
Transfers between
funds
16 2 (2)
Net movement
in funds
18 349 143 492 23D
Fund balances
brought
forward at 1 April 1,087 1,554 1,324
Fund balances carried forward at 31 March 816 1,23D 2,046 1,554

Note Unrestricted Restricted Total at31 Total at 31
Funds Funds March 2021 March 2020
FOOD 5000 8000 8000
Fixed Assets
Investments 13 551 BDO 1,351 1 113
Total fixed assets 551 800 1,351 1,118
Current Assets
Debtors and accrued income 14 250 30 280 14
Cash and cash equivalents 67 453 520 455
Total current assets 317 483 800 469
Current
liabilities
Creditors: Amounts falling due
within one year 15 52 53 105 33
Net current assets 265 430 695 436
Total assets less current liabilities 816 1,230 2,046 1,554
Net Assets 816 1,230 2,046 1,554
The funds ofthe charity
Restricted
income funds
1,230 1,230 1,087
Unrestricted
income
funds 816 816 467
Total Charity Funds 19 816 1,230 2,046 1,554

Note
2020I21 2019I20
2000 5000
Cash flows from operating activities:
Net cash used in operating acflvifles 18 25 222
Cash flows from investing activities:
Dividends and interest from investments 13.3 40 39
Proceeds from sale of investments
Net cash provided
by investing
activities
40 39
Change in cash and cash equivalents in the reporting period 65 261
Increase in cash and cash equivalents in lhe year 65 261
Cash and cash equivalents at the beginning of
reporting period 455 194
Total cash and cash equivalents
at the end
520 455
ofthe year

Payments to Receilpts from Receilpts from Amounts owed Amounts due
related parties related parties to related parties from related
parties
EOOO f000 f000 FOOD
Declaration of Interest
2020/21
Optimus Health Ltd 250
NTH Solutions LLP
2019/20
Optimus Health Ltd 175
NTH Solutions LLP
Optimus Health Ltd
(Trading Company for North Tees and Harilepool NHS Foundation Trust)

Unrestricted Restricted Total Total
Funds Funds 2020/21 2019/20
ROOD FOOD RDOO RODO
Donations 2 79 81 135
Fundraising Income Generated by Donors 11 19 30 8
Grants Receivable 173 173
Corporate Donations 250 7 257 194
GIR Aid 4 2 6 4
Legacies 16 16 1'I8
Total 123 663

The income was pri marily
from the prov
ision oftraining courses in furtherance
oft
he Charity's
obje
ctives.
Unrestricted Restricted Total Total
Funds Funds 2020/21 2019/20
FOOD ROOD ROOD RDDD
Income from the provision
ofeducation and training 20 20 15
Total 20 20 15
5.Other Trading Activities
Unrestricted Restricted Total Total
Funds Funds 2020/21 2019/20
FOOD FOOD ROOD ROOD
Staff Lotlery deductions 17 17
Total 17 17
6. Other incoming Resources
Unrestricted Restricted Total Total
Funds Funds 2020/21 2019/20
ROOD ROOD FOOD FODO
Other Income 61 5 66 100
Total 61 5 66 100

2020/21 2019/20
EOOO EOOO
Staff Lottery Winnings &Admin 12
Total 12

2020/21 2019/20
EOOO EOOO
Purchase of Equipment 143 60
Research Posts and Clinical Care 29 72
Refurbishment
Costs & IT Equipment
38 80
Staff Education and Welfare 178 62
Patients Welfare 10 37
Total 398 311

The investment
is v
The investment
is v
alued at bid alued at bid alued at bid price 2020/21.
13.1 Movement
In
fixed asset investment 2020/21 2019/20
Total Total
6000 8000
Market value brought forward 1,118 1,155
Monies owed by CCLA for Charities 10 10
Short tenn dividends (10) (10)
Less disposals at carrying value
Net (loss)/gain on revaluation 233
Market value at 31 March 1,351 1,118
13.2 Market value at 31 March 2020/21 2019/2D
Total Total
8000 F.ODD
Held In UK
COIF Charities
Investment
Fund 1,351 1,118
Total 1,351 1,118
The COIF Charities Investment Fund includes the following investments:
2020/21 2019/20
Asset allocation
Ovemeas
Equities
67.23% 80.21%
UK Equities 9.S9% 12.60%
Infrastructure &Operating Assets 9.12% 968%
Cash &near cash 4.83% 620%
Property 3.90% 5.37%
Contractual
8
Other Income 268% 3.25%
Private Equity 8 Other 2.01% 2.15%
Fixed Interest 0.34% 0.54%

13.3 Total gross Income from inves tments
and cash on deposit
2020/21 2019/20
Total Total
EOOO EOOO
Held in UK
Investments 39
Total 40 39

Debtors under one year 2020/21 2019/20
Total Total
f000 EOOO
Dividend Income 10 10
Prepayments 4 4
Accrued Income 266
Total 260 14

Creditors under one year under one year 2020/21 2020/21 2019/20
Total Total
EOOO E000
Accruals 64 'I9
Deferred Income 9 9
Amounts owed to North Tees and Hartlepool NHS 32 5
Foundation
Trust
Total 105
There is no security for non-trading amounts owed to the Foundation Trust.
16. Transfers between funds 2020/21 2019/20
Total Total
f000 EOOO
Transfers

2020/21 2019/20
Total Total
5000 5000
Net movement
in funds
492 230
(Gain)/Loss
on investments
(233) 37
Deduct interest/dividends income shown
in investing
activities
(40) (39)
(Increase)/ Decrease in debtors (266) (3)
Increase/(Decrease) in creditors 72 (3)
Net cash generated from operating activities 25 222

19.Analysis o fC hadta bl e
Funds
Fund Balances Incoming Resources Internal Fund Balances
at 31March 2020 Resources Expended Transfers al 31March 2021
flame Deva//pr/cn
ofthe nature end purpose
cfthe fund &000 2000 &000 ROOD EDOO
OVER &25,000 OVER &25,000
To support
patient cere within the Directorate of
t Memorial
Fund
(Surgery ) Surgery 45 51
To support patient care within breast service
2 Breast Surgery Fund Indudlng
equipmenl
&training
62 75
To support patient care for individuals requiring
9 Spinal Fund treabnent
vnthln
the Spinal Deparlmenl
47 48
To support
patient care fcr individuals
with blood
4 Haematclogy
Fund
disorders 113 21 (10) 124
To support
patlenl care for individuals
diagnosed
5 Urofogy Research Fund with Urology/Kidney
refsted IUness
33 38
a M Legacy Fund To support
the purchase
ofequipment
benefit ofcancer patients
for the 162 43 (52) 153
To supped
patient cere for Individuals
requirfng
7 Cardiology
Fund
9 Neo-Natal
treatment
within the Cardiac unit
Tosupport
patient care for Individuals
Ireatmenl
within the neo.natal unit
requiring 1DO
32
19 (3)
(9)
116
28
To support stroke patilenh
welfare and
staff
9 Stroke Fund training
To support
Colorectal patient services.
staff 37 16 (10) 43
to Colorec!sl Cancer Fund EducaUon
&Training
(4) 30
11 Neonatal
Life Support
Support
running cfLlfe Suppcrl coume
28 18 (5) 41
Breast Cancer nurse training
/ Welfare
&
r2 Sreast Care Nursing Fund hardship
fund fcrpatients
88
Tosupport
patient care for Individuals
requiring
ts Chemotherapy
Fund
treabnenlwUhln
Chemotherapy
Fund UHNT
49 21 (17) 53
Funds increased toabove 526,000as st 31Igarch 2021
Removed funds decreased to below &25,DOD as at31&larch 2021
Funds at 31 March 202'I 771 217 (122) 866
Other Funds balances less than &25000ss al 31stMarch 2021 316 123 (73) (2)
Total Reslrl cled Funds 1,097 34D 196 2 1,230
Totaf Unrestricted Funds 467 599 (252) 816
Total Fund balances at 31 Ii/larch 2D21 1,654 939 447 2,046
fntemal Transfem Movement
between
restrldad
snd unrestricted
funds